MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Muller Fabbri(The University of Texas MD Anderson Cancer Center), Carlo M. Croce(The Ohio State University), Francesca Lovat(Cancer Genetics (United States)), Nicola Zanesi, Danilo Perrotti(Cancer Genetics (United States)), Federica Calore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Melissa Crawford, Ramasamy Santhanam, Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Dorothee Wernicke, Alessio Paone(Istituto Pasteur), Charlene Mao, Gülçin Özer, Gerard J. Nuovo(CS Diagnostics), Patrick Nana‐Sinkam, Eugenio Gaudio(Institute of Oncology Research), Roberta Galli(Ospedale Filippo Del Ponte Varese), Paolo Fadda(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Hansjüerg Alder(The Ohio State University)
Cited by 1,547
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
|Translational research|2020|2.3k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k